Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Health collaborations forged at CIIE begin to bear fruit

By ZHOU WENTING in Shanghai | China Daily | Updated: 2021-01-19 10:10
Share
Share - WeChat
The stall of Novo Nordisk at the third China International Import Expo in Shanghai. [Photo/Xinhua]

Medical procedures, drugs, online programs serve patients, public across country

Two months after the third China International Import Expo ended in Shanghai, some exhibitors from the healthcare sector have disclosed that collaborations forged during the event have now materialized in the form of new drugs, innovative systems and technologies benefiting patients and the general public.

It transpires that several agreements were clinched between pharmaceutical multinationals and local healthcare authorities, institutions, schools and enterprises during the third CIIE.

Their partnerships' objective is to exploit inherent advantages and synergies in order to make the healthcare ecosystem in the country more innovative.

Executives of US-headquartered Boston Scientific said they had forged a strategic collaboration with Vivolight, a medical imaging device and technology provider based in Shenzhen, Guangdong province, during the third CIIE.

Their partnership may help drive improved clinical outcomes and technological progress in percutaneous coronary intervention, or PCI, procedures at hospitals.

This is said to be the first-ever strategic cooperation between a foreign enterprise and a local counterpart in the field of coronary intervention imaging.

The collaboration combines Boston Scientific's advantage in intravascular ultrasound and Vivolight's competitiveness in optical coherence tomography to provide patients with more accurate medical solutions for better treatment.

Experts said PCI procedures guided by imaging techniques such as IVUS and vascular OCT can significantly reduce the incidence of serious adverse events by making up for the lack of coronary angiography.

Industry experts said IVUS applied in intervention has been regarded as the "gold standard" in accordance with guidance from Europe and the United States.

However, in China, only 8 percent of PCI procedures are guided by imaging techniques, which compares with 15 percent in the US and more than 90 percent in Japan.

"For Boston Scientific, an important impetus of continuous growth in the China market is to collaborate with local partners to satisfy more local patients' unmet needs through diversified innovative channels," the company said in a written reply.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产精品嫩草影院线路| 日本特级淫片免费| 动漫痴汉电车1~6集在线| 亚洲图片欧美另类| 女人扒下裤让男人桶到爽| 久久狠狠躁免费观看| 欧美色图亚洲激情| 四虎影视在线影院www| 日韩色图在线观看| 在线私拍国产福利精品| 中文字幕在线亚洲精品| 朱竹清被吸乳羞羞漫画| 亚洲综合精品第一页| 美女网站在线观看视频18| 国产成人福利精品视频| 91福利免费视频| 开心五月激情综合婷婷| 久久国产色AV免费观看| 欧美在线一级精品| 人人妻人人澡人人爽欧美一区双| 色欲色av免费观看| 国产精品99久久久久久猫咪| aisaobi| 无码av专区丝袜专区| 乱子伦一级在线现看| 欧美精品一区二区精品久久| 免费观看性生交大片人| 色婷婷久久综合中文久久蜜桃| 国产男人女人做性全过程视频| 99久在线精品99re6视频| 性xxxxfreexxxxx国产| 久久国产乱子伦精品免费一| 欧美人与动人物xxxx| 亚洲色大成网站WWW尤物| 精品国自产拍天天拍2021| 国产动作大片中文字幕| 亚洲色图15p| 国产综合久久久久| a在线免费观看视频| 性欧美18-19sex性高清播放| 久久久久亚洲Av片无码下载蜜桃|